Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edip Erkus

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|October 30, 2018
Mean Platelet Volume to Lymphocyte Ratio as a Novel Marker for Diabetic NephropathyMehmet Zahid Kocak, Gulali Aktas, Edip Erkus, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|September 30, 2018
A Case of Secondary Hypertension due to Giant Hydatid CystBurcin Atak, Gulali Aktas, M Zahid Kocak, et al.
Acta Clinica Croatica|January 24, 2020
MEAN PLATELET VOLUME: AN OVERLOOKED HERALD OF MALIGNANT THYROID NODULESMustafa Sit, Gulali Aktas, Bahri Ozer, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|April 5, 2018
A Case of Sitagliptin-Induced Mild Acute PancreatitisMehmet Zahid Kocak, Gulali Aktas, Edip Erkus, et al.
Swiss Medical Weekly|October 28, 2019
Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitusMehmet Z Kocak, Gulali Aktas, Edip Erkus, et al.
European Journal of Clinical Investigation|January 31, 2020
Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus?Mehmet Zahid Kocak, Gulali Aktas, Burcin M Atak, et al.
Clinical Laboratory|June 27, 2018
A Rare Non-Hemolytic Case of Idiopathic Cold Agglutinin DiseaseEdip Erkus, Mehmet Z Kocak, Gulali Aktas, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|October 12, 2017
Could Red Cell Distribution Width be a Marker of Thyroid Cancer?Gulali Aktas, Mustafa Sit, Ibrahim Karagoz, et al.
Clinical Kidney Journal|January 15, 2026
Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB StudyOzkan Gungor, Berfu Korucu, Ebru Gok Oguz, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|October 30, 2018
Mean Platelet Volume to Lymphocyte Ratio as a Novel Marker for Diabetic NephropathyMehmet Zahid Kocak, Gulali Aktas, Edip Erkus, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|September 30, 2018
A Case of Secondary Hypertension due to Giant Hydatid CystBurcin Atak, Gulali Aktas, M Zahid Kocak, et al.
Acta Clinica Croatica|January 24, 2020
MEAN PLATELET VOLUME: AN OVERLOOKED HERALD OF MALIGNANT THYROID NODULESMustafa Sit, Gulali Aktas, Bahri Ozer, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|April 5, 2018
A Case of Sitagliptin-Induced Mild Acute PancreatitisMehmet Zahid Kocak, Gulali Aktas, Edip Erkus, et al.
Swiss Medical Weekly|October 28, 2019
Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitusMehmet Z Kocak, Gulali Aktas, Edip Erkus, et al.
European Journal of Clinical Investigation|January 31, 2020
Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus?Mehmet Zahid Kocak, Gulali Aktas, Burcin M Atak, et al.
Clinical Laboratory|June 27, 2018
A Rare Non-Hemolytic Case of Idiopathic Cold Agglutinin DiseaseEdip Erkus, Mehmet Z Kocak, Gulali Aktas, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|October 12, 2017
Could Red Cell Distribution Width be a Marker of Thyroid Cancer?Gulali Aktas, Mustafa Sit, Ibrahim Karagoz, et al.
Clinical Kidney Journal|January 15, 2026
Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB StudyOzkan Gungor, Berfu Korucu, Ebru Gok Oguz, et al.
Pageof 2